Clinical Trials in Minneapolis

Showing 2761-2780 of 6,957 trials

A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

NCT04614467

This clinical trial will explore the efficacy and safety of GCSF-mobilized autologous CD34+ cells for the treatment of CMD in adults currently experiencing angina and with no obstructive coronary artery disease. Eligible subjects will receive a single administration of CLBS16 or placebo.

Coronary Microvascular DysfunctionCoronary Microvascular DiseaseMicrovascular Coronary Artery Disease

Lisata Therapeutics, Inc.34 participantsStarted Oct 2020

Los Angeles, California, United States • Gainesville, Florida, United States • Hollywood, Florida, United States +4 more locations

COMPLETEDPhase 2< 1 mile

IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer

NCT03054909

This is a single center, randomized phase II study of an IL-15Rα-Fc super-agonist complex (ALT-803) given as maintenance therapy after the completion of 1st line IV/IP chemotherapy for the treatment of advanced ovarian, fallopian tube, and primary peritoneal cancer.

FIGO Stage III and IV Ovarian CancerFIGO Stage III and IV Fallopian Tube CancerFIGO Stage III Primary Peritoneal Cancer

Masonic Cancer Center, University of Minnesota7 participantsStarted Sep 2017

Minneapolis, Minnesota, United States

A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer

Find Trials by Condition in Minneapolis

Alignment Comparison Between TruMatch™ Personalized Solutions and Conventional Total Knee Replacement Instrumentation

A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)

A Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Sitravatinib

Long-term Outcomes of Selective Dorsal Rhizotomy Among Individuals With Cerebral Palsy

Study of the CAT RX Aspiration Catheter When Used in Patients With Large Occlusive Thrombus in Coronary Arteries

177Lu-DTPA-Omburtamab Radioimmunotherapy for Recurrent or Refractory Medulloblastoma

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

In-Stent Restenosis Post-Approval Study

Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC

Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease

Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis

A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis

FoxBioNet: ECV (Extracellular Vesicle) 004

Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants

A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis

Exacerbations and Their Outcomes International (EXACOS International)